patent/WO-03024926-A3

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03024926-A3

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0e475df9c28a0b164753995c9c98377b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f678fbbf5e3f25560872a2e6172c1203 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_79441b863b09c9440bfad45c8bb17993 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_548d89d8c74679739d0d8ffa0cea173c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e5d9420b3828c357854ad73f0c5024ad http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0c621ae044a628443e964ec61b9f8ee6
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D453-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D251-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D251-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D251-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D251-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D251-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D251-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D251-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D251-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D251-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D251-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D453-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D251-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D251-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate	2002-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c885298cf6273a344fc0a2130eda6311 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6db708aea31b6b57fd1fef8329abbac http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a85109ed9d865f6d1696aeae560eff99 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d05cd181eea411b3242c5456a732f984 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00f57405c81eeffd8e998145754c7ac4
publicationDate	2003-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	WO-03024926-A3
titleOfInvention	Methods and compositions of novel triazine compounds
abstract	The present invention relates to methods and compositions comprising compounds that treat pathophysiological conditions arising from inflammatory responses. In particular, the present invention is directed to compounds that inhibit or block glycated protein produced induction of the signaling-associated inflammatory response in endothelial cells. The present invention relates to compounds that inhibit smooth muscle proliferation. In particular, the present invention is directed to compounds that inhibit smooth muscle cell proliferation by modulating HSPGs such as Perlecan. The present invention further relates to the use of compounds to treat vascular occlusive conditions characterized by smooth muscle proliferation such as restenosis and atherosclerosis.
priorityDate	2001-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate

Subject

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9708156-A1

http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7541
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3771872
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226403877
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3339
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID36771
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID15530
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID8620257
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP98160

Total number of triples: 66.